Cargando…
HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants
[Image: see text] Integrase strand transfer inhibitors (INSTIs) block the integration step of the retroviral lifecycle and are first-line drugs used for the treatment of HIV-1/AIDS. INSTIs have a polycyclic core with heteroatom triads, chelate the metal ions at the active site, and have a halobenzyl...
Autores principales: | Smith, Steven J., Zhao, Xue Zhi, Passos, Dario Oliveira, Pye, Valerie E., Cherepanov, Peter, Lyumkis, Dmitry, Burke, Terrence R., Hughes, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205226/ https://www.ncbi.nlm.nih.gov/pubmed/33686850 http://dx.doi.org/10.1021/acsinfecdis.0c00819 |
Ejemplares similares
-
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
por: Smith, Steven J., et al.
Publicado: (2021) -
HIV-1 Integrase Strand Transfer Inhibitors
with Reduced Susceptibility to Drug Resistant Mutant Integrases
por: Zhao, Xue Zhi, et al.
Publicado: (2016) -
Structure-Guided
Optimization of HIV Integrase Strand
Transfer Inhibitors
por: Zhao, Xue Zhi, et al.
Publicado: (2017) -
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
por: Smith, Steven J., et al.
Publicado: (2018) -
Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing
HIV-1 Integrase Inhibitors Having High Antiviral Potency against
Cells Harboring Raltegravir-Resistant Integrase Mutants
por: Zhao, Xue Zhi, et al.
Publicado: (2014)